![](/img/cover-not-exists.png)
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study :
Banerjee, A., Lane, D. A., Torp-Pedersen, C., Lip, G. Y. H.Volume:
107
Year:
2012
Language:
english
Pages:
6
DOI:
10.1160/th11-11-0784
File:
PDF, 159 KB
english, 2012